| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/17/1998 | EP0847401A1 Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
| 06/17/1998 | CN1038728C IBDV prodn. in continuous lines |
| 06/16/1998 | US5767251 Polypeptides |
| 06/16/1998 | US5766919 Replication of hepatitis C virus genome and identification of virus having high infectivity |
| 06/16/1998 | US5766906 Deletion mutation in 5'nontranslated region of viral genome |
| 06/16/1998 | US5766892 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic |
| 06/16/1998 | US5766885 Producing heterologous proteins in plants susceptible to a polyprotein-producing plant virus, e.g. insulin |
| 06/16/1998 | US5766882 recombinant poxviruses with foreign DNA in essential regions |
| 06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
| 06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
| 06/16/1998 | US5766603 Producing live, attenuated hepatitis a vaccine by in vitro passage of virus in susceptible cell cultures without prior passage in subhuman primates |
| 06/16/1998 | US5766602 Recombinant packaging defective Sindbis virus vaccines |
| 06/16/1998 | US5766599 Attenuated virus; genetic engineering |
| 06/16/1998 | US5766597 Vaccines providing immunity against plasmodium infections |
| 06/11/1998 | WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
| 06/11/1998 | WO1998024479A1 Adeno-associated viral vector-mediated delivery of dna to cells of the liver |
| 06/11/1998 | CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
| 06/10/1998 | EP0846183A2 High efficiency retroviral packaging system |
| 06/10/1998 | EP0846181A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
| 06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
| 06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 06/10/1998 | CN1184504A Recombinant baculovirus insecticides |
| 06/09/1998 | US5763269 Recombinant infectious bovine rhinotrocheitis virus |
| 06/09/1998 | US5763268 Hepatitis delta virus compositions and expression vectors |
| 06/09/1998 | US5763253 Methods of preparing tissue plasiminogen activator derivative composition |
| 06/09/1998 | US5763251 Viral products |
| 06/09/1998 | US5762938 Modified recombinant vaccinia virus and expression vectors thereof |
| 06/09/1998 | US5762924 Wherein heterologous dna is located in the genome at the site of spindle protin gene; pesticides, insecticides |
| 06/04/1998 | WO1998023754A1 Process for the expression of genes of the dengue viruses |
| 06/04/1998 | WO1998023729A1 In vitro model for hiv and other viral diseases |
| 06/04/1998 | WO1998023148A1 A baculovirus for the control of insect pests |
| 06/04/1998 | CA2269768A1 In vitro model for hiv and other viral diseases |
| 06/03/1998 | EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1998 | EP0844888A1 Tissue specific viral vectors |
| 06/02/1998 | US5759817 Heterodimeric receptor libraries using phagemids |
| 06/02/1998 | US5759808 Immunoglobulins devoid of light chains |
| 06/02/1998 | US5759790 Von Hippel - Lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene |
| 06/02/1998 | US5759770 Retrovirus from the HIV group and its use |
| 06/02/1998 | US5759553 Polypeptides |
| 06/02/1998 | US5759552 Marek's disease virus recombinant poxvirus vaccine |
| 05/28/1998 | WO1998022607A1 Method for producing recombinant virus |
| 05/28/1998 | WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 05/28/1998 | WO1998022588A2 An improved method for the production and purification of adenoviral vectors |
| 05/28/1998 | WO1998022150A1 Method and apparatus for inactivating contaminants in biological fluid |
| 05/28/1998 | CA2271437A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 05/27/1998 | EP0844306A1 Methods of producing members of specific binding pairs |
| 05/27/1998 | EP0843732A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 05/27/1998 | CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/26/1998 | US5756670 Method and means for producing an immunoglobulin-binding protein |
| 05/26/1998 | US5756341 Culturing monkey kidey cells in serum-free medium, infecting with influenza virus having modified cleavage site, incubating to produce antigen, removing portion, contacting with protease which activates virus, adding inhibitor, returning to culture |
| 05/26/1998 | US5756340 Insect control with multiple toxins |
| 05/26/1998 | US5756284 Self-assembling recombinant papillomavirus capsid proteins |
| 05/26/1998 | US5756281 Stealth virus detection in the chronic fatigue syndrome |
| 05/26/1998 | US5756103 Alvac canarypox virus recombinants comprising heterlogous inserts |
| 05/26/1998 | US5756102 Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
| 05/26/1998 | US5756101 Malaria recombinant poxvirus |
| 05/26/1998 | US5756086 Gene expression; anticarcinogenic agents |
| 05/22/1998 | WO1998021350A1 Diminishing viral gene expression by promoter replacement |
| 05/22/1998 | WO1998021349A1 Novel constructs and vectors for the targeted and inducible expression of genes |
| 05/22/1998 | WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 05/22/1998 | WO1998021317A1 Viral variants and methods for detecting same |
| 05/22/1998 | WO1998011244A3 AAV4 vector and uses thereof |
| 05/22/1998 | CA2271951A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 05/22/1998 | CA2269864A1 Novel constructs and vectors for the targeted and inducible expression of genes |
| 05/20/1998 | EP0842287A1 High efficiency helper system for aav vector production |
| 05/20/1998 | EP0842279A2 Helper viruses for preparing recombinant viral vectors |
| 05/20/1998 | EP0841943A1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 05/20/1998 | EP0841942A1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 05/19/1998 | US5753500 Helper-free stocks of recombinant adeno-associated virus vectors |
| 05/19/1998 | US5753490 Recombinant HIV and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 05/19/1998 | US5753489 Method for producing viruses and vaccines in serum-free culture |
| 05/19/1998 | US5753488 Isolated stealth viruses and related vaccines |
| 05/19/1998 | US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression |
| 05/19/1998 | US5753235 Recombinant canine herpesviruses |
| 05/19/1998 | US5753220 Cysteine protease gene defective baculovirus, process for its production, and process for the production of economic protein by using the same |
| 05/14/1998 | WO1998020343A2 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 05/14/1998 | WO1998010085A3 Gene therapy for congestive heart failure |
| 05/14/1998 | WO1998004286A3 Assembly-deficient herpesvirus vaccine |
| 05/13/1998 | EP0840795A1 Helper virus-free herpesvirus vector packaging system |
| 05/13/1998 | EP0840624A1 Method and apparatus for inactivating contaminants in blood products |
| 05/13/1998 | EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 05/13/1998 | EP0573614B1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 05/12/1998 | US5750398 Vector, element and method for inhibiting immune recognition |
| 05/12/1998 | US5750396 Stable virus packaging cell lines |
| 05/12/1998 | US5750384 L5 shuttle phasmids |
| 05/12/1998 | US5750113 An isolated infectious bronchitis virus (ibv) of the same serotype as that of the ibv strain 4/91 deposit; attenuation |
| 05/12/1998 | US5750112 Canine coronavirus vaccine from feline enteric coronavirus |
| 05/12/1998 | US5750111 Mild newcastle disease virus vaccine |
| 05/12/1998 | US5750109 Gene coding; neutralization antigen |
| 05/07/1998 | WO1998018950A2 Aav-dna helper virus sequences |
| 05/07/1998 | WO1998018908A1 Systems and methods for removing viral agents from blood |
| 05/07/1998 | WO1998018809A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 05/07/1998 | CA2269738A1 Targeted cytolysis of cancer cells |
| 05/07/1998 | CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/06/1998 | EP0839199A1 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 05/06/1998 | EP0839184A1 Synthetic hpv11 virus-like particles |